Er-165 is a radiolanthanide, usually in trivalent state. The ionic radius of Er3+ is 89 pm, i.e. just 3% larger than Lu3+, which explains that chelators suitable for Lu-177 can be directly employed for Er-165 too, in particular DOTA.
Er-165 decays by electron capture decay with a half-life of 10.36 hours to stable Ho-165.
Er-165 emits no gamma-rays, but X-rays, notably Kα at ≈47 keV (59.4(9) %) and Kβ at ≈54 keV (14.3(19) %). These energies make Er-165 suitable for SPECT-imaging.
The mean photon energy per decay is 37 keV and the mean electron energy emitted per decay is 5 keV . Most electrons are short-range Auger electrons with <1 µm and <26 µm respectively. Er-165 has therefore been proposed as therapeutic Auger electron emitter .
Er-165 is produced by proton irradiation of natural Ho carbonate targets at Hevesy Laboratory at DTU. A Ho/Er separation is performed by ion exchange chromatography.
Activity will be shipped from the PRISMAP facility Hevesy Laboratory (DTU, Risø, Denmark) to the users in form of Er3+ solution.
Parameter | Specifications |
---|---|
Half-life | 10.36 h |
Daughter | Stable Ho-165 |
Branching Ratio/Decay | 100% EC |
Production | Ho-165(p,n)Er-165 |
Purification | multi-step ion exchange |
Chemical Form | Er3+ ion in 0.1 M HCl solution (1-2 ml) |
Specific Activity | t.b.d. |
Radionuclidic Purity | t.b.d. |
Radiochemical Purity | t.b.d. |
Chemical Purity | Metal impurities determined by ICP-OES for each batch. |
Identification | X-ray spectroscopy and half-life |
Appearance | Clear colourless solution |
pH | 1 |
Activity available | 1 GBq (more to be discussed) |
Availability | Upon request |
Grade | Research grade, n.c.a. |
Other information | Bioburden and endotoxin burden can be analysed post release, upon request. |